Skip to main content

Tivantinib plus erlotinib may benefit high MET expression non–small cell lung cancers

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Tivantinib plus erlotinib may benefit high MET expression non–small cell lung cancers

User login

Username

Password

Reset your password

Type	Lead	score